A Study of Fortigel Testosterone Gel 2% in Males With Low Testosterone
Clinical trial NCT00522431 · COMPLETED
Trial details
- NCT number
- NCT00522431
- Sponsor
- Endo USA Inc., a Keenova Therapeutics Company
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2007-08-01
- Primary completion
- 2008-03-01
- Enrollment
- 149
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.